Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review

被引：8
|
作者：
Chen, Dawei [1 ,2 ]
Zhang, Yan [2 ]
Shi, Fang [2 ]
Li, Minghuan [2 ]
Zhu, Hui [2 ]
Kong, Li [2 ]
Yu, Jinming [2 ]
机构：
[1] Weifang Med Univ, Weifang, Peoples R China
[2] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Shandong, Peoples R China
来源：
ONCOTARGETS AND THERAPY | 2015年 / 8卷
关键词：
bevacizumab; lung cancer; malignant pericardial effusion; ENDOTHELIAL GROWTH-FACTOR; PLEURAL EFFUSIONS; CISPLATIN; ASCITES;
D O I：
10.2147/OTT.S90145
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Malignant pericardial effusion (MPCE) is a common complication of advanced malignant tumors, and interferes severely with patient prognosis and quality of life. The standard treatment for this complication is intracavitary perfusion of chemotherapeutic drugs, which is limited by unsatisfactory therapeutic effects and serious adverse events. We report a patient with MPCE who was treated with bevacizumab by pericardial perfusion, resulting in a complete response. This case supports the use of intrapericardial bevacizumab as a potential treatment for MPCE.
引用
收藏
页码：2767 / 2770
页数：4
相关论文
共 50 条
  • [21] A lung cancer patient with deep vein thrombosis:a case report and literature review
    Yungu Chen
    Yiu Sing Tsang
    Xiaoxia Chou
    Jiong Hu
    Qing Xia
    BMC Cancer, 19
  • [22] Response of paraneoplastic nephrotic syndrome to corticosteroids combined with chemotherapy for advanced lung cancer: a case report and literature review
    Yu Fujita
    Satoru Ishii
    Satoshi Hirano
    Shinyu Izumi
    Yuichiro Takeda
    Nobuyuki Kobayashi
    International Cancer Conference Journal, 2012, 1 (2) : 88 - 92
  • [23] Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
    Kong, Ying
    Xu, Xiao-Cheng
    Hong, Liang
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (19) : 6507 - 6513
  • [24] Response of paraneoplastic nephrotic syndrome to corticosteroids combined with chemotherapy for advanced lung cancer: a case report and literature review
    Fujita, Yu
    Ishii, Satoru
    Hirano, Satoshi
    Izumi, Shinyu
    Takeda, Yuichiro
    Kobayashi, Nobuyuki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2012, 1 (02): : 88 - 92
  • [25] Primary malignant melanoma of the lung: a case report and literature review
    Deng Shuangshuang
    Sun Xiaobo
    Zhu Zhen
    Lu Jingjing
    Wen Guanghua
    Chang Xuejiao
    Gao Hui
    Hua Yanfei
    Wang Lumei
    Gao Jinli
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [26] Primary malignant melanoma of the lung: a case report and literature review
    Shuangshuang Deng
    Xiaobo Sun
    Zhen Zhu
    Jingjing Lu
    Guanghua Wen
    Xuejiao Chang
    Hui Gao
    Yanfei Hua
    Lumei Wang
    Jinli Gao
    BMC Pulmonary Medicine, 20
  • [27] Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report
    Li, You
    Liu, Yu
    Zhao, Zichen
    Zhang, Yan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 629 - 636
  • [28] Fractured esophageal self-expandable metallic stent in a patient with advanced lung cancer: a case report and review of the literature
    Ilker Turan
    Fatih Tekin
    Galip Ersoz
    Oktay Tekesin
    Omer Ozutemiz
    Esophagus, 2015, 12 : 82 - 85
  • [29] Fractured esophageal self-expandable metallic stent in a patient with advanced lung cancer: a case report and review of the literature
    Turan, Ilker
    Tekin, Fatih
    Ersoz, Galip
    Tekesin, Oktay
    Ozutemiz, Omer
    ESOPHAGUS, 2015, 12 (01) : 82 - 85
  • [30] Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature
    Takada, Satoshi
    Hoshino, Yoshinori
    Ito, Homare
    Masugi, Yohei
    Terauchi, Toshiaki
    Endo, Kazuhiro
    Kimata, Masaru
    Furukawa, Junji
    Shinozaki, Hiroharu
    Kobayashi, Kenji
    Ogata, Yoshiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (03) : 286 - 290
12345